PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Molecular Medicine Department, Institute of Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran.\', \'Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.\', \'Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.\', \'Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.\', \'Department of Pulmonary Medicine, Koc University School of Medicine, Koc University Research Center for Translational Medicine (KUTTAM), Istanbul, Turkey.\', \'Mycobacteriology Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.\', \'National Heart and Lung Institute, Imperial College London and the NIHR Imperial Biomedical Research Centre, London, United Kingdom.\', \'Priority Research Centre for Asthma and Respiratory Disease, Hunter Medical Research Institute, University of Newcastle, Newcastle, NSW, Australia.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/fcimb.2021.563085
?:hasPublicationType
?:journal
  • Frontiers in cellular and infection microbiology
is ?:pmid of
?:pmid
?:pmid
  • 33643932
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.703
?:rankingScore_hIndex
  • 43
?:title
  • COVID-19: Molecular and Cellular Response.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all